1. Home
  2. VTRS vs STLA Comparison

VTRS vs STLA Comparison

Compare VTRS & STLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$20.79

Market Cap

21.0B

Sector

Health Care

ML Signal

N/A

Logo Stellantis N.V.

STLA

Stellantis N.V.

N/A

Current Price

$3.84

Market Cap

20.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
VTRS
STLA
Founded
1961
2021
Country
United States
Netherlands
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
21.0B
20.2B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
VTRS
STLA
Price
$20.79
$3.84
Analyst Decision
Buy
Hold
Analyst Count
12
7
Target Price
★ $21.00
$6.39
AVG Volume (30 Days)
9.0M
★ 35.0M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
★ 2.32%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $14,299,900,000.00
N/A
Revenue This Year
$3.53
$4.94
Revenue Next Year
$3.69
$2.21
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$10.15
$3.86
52 Week High
$21.20
$12.22

Technical Indicators

Market Signals
Indicator
VTRS
STLA
Relative Strength Index (RSI) 71.15 33.40
Support Level $16.02 N/A
Resistance Level N/A $4.83
Average True Range (ATR) 0.58 0.17
MACD 0.17 -0.05
Stochastic Oscillator 87.62 0.38

Price Performance

Historical Comparison
VTRS
STLA

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

About STLA Stellantis N.V.

Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2025, it sold 5.6 million vehicles, 45%, 26%, and 18% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.

Share on Social Networks: